Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Treatment Use of 3,4-Diaminopyridine

Expanded access is currently available for this treatment.
Verified January 2017 by Duke University
Sponsor:
Information provided by (Responsible Party):
Vern C. Juel, M.D., Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT01765140
First received: January 6, 2013
Last updated: January 23, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is currently available for this treatment.
  Study Completion Date: No date given
  Primary Completion Date: No date given